These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 28133798)

  • 1. Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem.
    Havenar-Daughton C; Lee JH; Crotty S
    Immunol Rev; 2017 Jan; 275(1):49-61. PubMed ID: 28133798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing T Follicular Helper Cell Responses for HIV Vaccine Development.
    Niessl J; Kaufmann DE
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29921828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of follicular helper CD4 T cells in the development of HIV-1 specific broadly neutralizing antibody responses.
    Moysi E; Petrovas C; Koup RA
    Retrovirology; 2018 Aug; 15(1):54. PubMed ID: 30081906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance.
    Cirelli KM; Carnathan DG; Nogal B; Martin JT; Rodriguez OL; Upadhyay AA; Enemuo CA; Gebru EH; Choe Y; Viviano F; Nakao C; Pauthner MG; Reiss S; Cottrell CA; Smith ML; Bastidas R; Gibson W; Wolabaugh AN; Melo MB; Cossette B; Kumar V; Patel NB; Tokatlian T; Menis S; Kulp DW; Burton DR; Murrell B; Schief WR; Bosinger SE; Ward AB; Watson CT; Silvestri G; Irvine DJ; Crotty S
    Cell; 2019 May; 177(5):1153-1171.e28. PubMed ID: 31080066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.
    Borrow P; Moody MA
    Immunol Rev; 2017 Jan; 275(1):62-78. PubMed ID: 28133804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging concepts on T follicular helper cell dynamics in HIV infection.
    Pissani F; Streeck H
    Trends Immunol; 2014 Jun; 35(6):278-86. PubMed ID: 24703588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell abnormalities and impact on antibody response in HIV infection.
    Noto A; Pantaleo G
    Curr Opin HIV AIDS; 2017 May; 12(3):203-208. PubMed ID: 28422784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses.
    Locci M; Havenar-Daughton C; Landais E; Wu J; Kroenke MA; Arlehamn CL; Su LF; Cubas R; Davis MM; Sette A; Haddad EK; ; Poignard P; Crotty S
    Immunity; 2013 Oct; 39(4):758-69. PubMed ID: 24035365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An HIV-1 envelope immunogen with W427S mutation in CD4 binding site induced more T follicular helper memory cells and reduced non-specific antibody responses.
    Yu HT; Tian D; Wang JY; Guo CX; Li Y; Wang X; Li D; Zhang FM; Zhuang M; Ling H
    PLoS One; 2014; 9(12):e115047. PubMed ID: 25546013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germinal center enhancement by extended antigen availability.
    Cirelli KM; Crotty S
    Curr Opin Immunol; 2017 Aug; 47():64-69. PubMed ID: 28738289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children.
    Roider J; Porterfield JZ; Ogongo P; Muenchhoff M; Adland E; Groll A; Morris L; Moore PL; Ndung'u T; Kløverpris H; Goulder PJR; Leslie A
    Front Immunol; 2019; 10():1497. PubMed ID: 31333650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoint modulation enhances HIV-1 antibody induction.
    Bradley T; Kuraoka M; Yeh CH; Tian M; Chen H; Cain DW; Chen X; Cheng C; Ellebedy AH; Parks R; Barr M; Sutherland LL; Scearce RM; Bowman CM; Bouton-Verville H; Santra S; Wiehe K; Lewis MG; Ogbe A; Borrow P; Montefiori D; Bonsignori M; Anthony Moody M; Verkoczy L; Saunders KO; Ahmed R; Mascola JR; Kelsoe G; Alt FW; Haynes BF
    Nat Commun; 2020 Feb; 11(1):948. PubMed ID: 32075963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of T
    Verma A; Schmidt BA; Elizaldi SR; Nguyen NK; Walter KA; Beck Z; Trinh HV; Dinasarapu AR; Lakshmanappa YS; Rane NN; Matyas GR; Rao M; Shen X; Tomaras GD; LaBranche CC; Reimann KA; Foehl DH; Gach JS; Forthal DN; Kozlowski PA; Amara RR; Iyer SS
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31827000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infection.
    Yamamoto T; Lynch RM; Gautam R; Matus-Nicodemos R; Schmidt SD; Boswell KL; Darko S; Wong P; Sheng Z; Petrovas C; McDermott AB; Seder RA; Keele BF; Shapiro L; Douek DC; Nishimura Y; Mascola JR; Martin MA; Koup RA
    Sci Transl Med; 2015 Jul; 7(298):298ra120. PubMed ID: 26223303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating CXCR5
    Martin-Gayo E; Cronin J; Hickman T; Ouyang Z; Lindqvist M; Kolb KE; Schulze Zur Wiesch J; Cubas R; Porichis F; Shalek AK; van Lunzen J; Haddad EK; Walker BD; Kaufmann DE; Lichterfeld M; Yu XG
    JCI Insight; 2017 Jan; 2(2):e89574. PubMed ID: 28138558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral Replicative Capacity, Antigen Availability via Hematogenous Spread, and High T
    Eldi P; Chaudhri G; Nutt SL; Newsome TP; Karupiah G
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of follicular helper T cells and the germinal center in HIV-1 gp120 DNA prime and gp120 protein boost vaccination.
    Hollister K; Chen Y; Wang S; Wu H; Mondal A; Clegg N; Lu S; Dent A
    Hum Vaccin Immunother; 2014; 10(7):1985-92. PubMed ID: 25424808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germinal Center Lymphocyte Ratios and Successful HIV Vaccines.
    Gonzalez-Figueroa P; Roco JA; Vinuesa CG
    Trends Mol Med; 2017 Feb; 23(2):95-97. PubMed ID: 28089302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.
    Ahmed Y; Tian M; Gao Y
    AIDS Res Ther; 2017 Sep; 14(1):50. PubMed ID: 28893278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design.
    Finney J; Kelsoe G
    Retrovirology; 2018 Jul; 15(1):53. PubMed ID: 30055635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.